COVID-19 Screening in Rheumatologic Diseases Cases; Special Look at Chloroquine Derivate Use

Soraya Shadmanfar; Gholamhosein Alishiri; Noushin Bayat; Morteza Izadi; Ahmad Salimzadeh; Abdolrahman Rostamian; Shahla Abolghasemi; Mohammad Hossein Azimzadeh Ardebili; Zeynab Rastgar Moqaddam; Marjan Hasani; Ehsan Rahmanian; Helia Iranpanah; Ghodrat Allah Islami; Amin Saburi

Volume 6, Issue 4 , December 2021, , Pages 141-147

https://doi.org/10.34172/hpr.2021.27

Abstract
  Background: Among suggested medications for the treatment of COVID-19, chloroquine derivates and angiotensin-converting–enzyme inhibitors (ACEIs)/angiotensin II type 1 receptor blockers (ARBs) are the two medications with conflicting effects on the development of the disease.Objectives: The present ...  Read More